Company Profiles

driven by the PitchBook Platform

Arisaph Pharmaceuticals

Description

Developer of therapies for cardiometabolic diseases and cancer. The company utilizes drug discovery platforms to develop differentiated medicines that act selectively on validated targets.

1999

Founded

PRIVATE

Status

Series H

Latest Deal Type

$2.5M

Latest Deal Amount

$28.5M

Total Amount Raised

3

Investors

Description

Developer of therapies for cardiometabolic diseases and cancer. The company utilizes drug discovery platforms to develop differentiated medicines that act selectively on validated targets.

Website:

www.arisaph.com

Formerly Known As

Triad Pharmaceuticals

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Biotechnology
Drug Discovery

Primary Office

155 Federal Street Suite 1602 Boston, MA 02110United States +1 (617) 986-4500
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Arisaph Pharmaceuticals's full profile, request a free trial.

Arisaph Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Arisaph Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Arisaph Pharmaceuticals Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Kos PharmaceuticalsCorporation000 0000000 0000
U.S. Department of Health and Human ServicesGovernment000 0000000 0000
Vatera Healthcare PartnersVenture CapitalMinority000 0000000 0000
Kos Pharmaceuticals Corporation
U.S. Department of Health and Human Services Government
Vatera Healthcare Partners Venture Capital

Arisaph Pharmaceuticals Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Christopher KiritsyCo-Founder, President, Board Member and Chief Executive Officer
Robert BaldiniConsultant of Corporate Development and Board Member
Joseph SuarezChief Business Officer and Vice President of Finance
William Bachovchin Ph.DCo-Founder, Executive Vice President, Chief Scientific Officer and Board Member
Michael JaharisBoard Member and Co-Founder
Christopher Kiritsy Co-Founder, President, Board Member and Chief Executive Officer
Robert Baldini Consultant of Corporate Development and Board Member
Joseph Suarez Chief Business Officer and Vice President of Finance
William Bachovchin Ph.D Co-Founder, Executive Vice President, Chief Scientific Officer and Board Member
Michael Jaharis Board Member and Co-Founder

Arisaph Pharmaceuticals Board Members (12)

NameRepresentingRoleSinceContact
Info
Antonio Gotto Jr.Vatera Healthcare PartnersAdvisor000 0000
Christopher KiritsyArisaph PharmaceuticalsCo-Founder, President, Board Member and Chief Executive Officer000 0000
Kevin FerroVatera Healthcare PartnersCo-Founder, Chief Executive Officer and Chief Investment Officer000 0000
Michael JaharisArisaph PharmaceuticalsBoard Member and Co-Founder000 0000
Nicolaos MadiasArisaph PharmaceuticalsBoard Member000 0000
Antonio Gotto Jr. Advisor Vatera Healthcare Partners
Christopher Kiritsy Co-Founder, President, Board Member and Chief Executive Officer Arisaph Pharmaceuticals
Kevin Ferro Co-Founder, Chief Executive Officer and Chief Investment Officer Vatera Healthcare Partners
Michael Jaharis Board Member and Co-Founder Arisaph Pharmaceuticals
Nicolaos Madias Board Member Arisaph Pharmaceuticals
Request full access to PitchBook